File Download

There are no files associated with this item.

Supplementary

Conference Paper: How to participate in conducting clinical trials on 1/4 of the novel drugs approved by the US FDA?

TitleHow to participate in conducting clinical trials on 1/4 of the novel drugs approved by the US FDA?
Other TitlesHow to conduct the clinical trials successfully for 1/4 approved products by FDA
Authors
Issue Date2018
Citation
3rd Shenzhen Clinical Research Forum, Shenzhen, China, 8 December 2018 How to Cite?
DescriptionKeynote speakers
Persistent Identifierhttp://hdl.handle.net/10722/283799

 

DC FieldValueLanguage
dc.contributor.authorYau, HKC-
dc.contributor.authorWong, CKW-
dc.date.accessioned2020-07-06T03:38:12Z-
dc.date.available2020-07-06T03:38:12Z-
dc.date.issued2018-
dc.identifier.citation3rd Shenzhen Clinical Research Forum, Shenzhen, China, 8 December 2018-
dc.identifier.urihttp://hdl.handle.net/10722/283799-
dc.descriptionKeynote speakers-
dc.languageeng-
dc.relation.ispartof3rd Shenzhen Clinical Research Forum-
dc.titleHow to participate in conducting clinical trials on 1/4 of the novel drugs approved by the US FDA?-
dc.title.alternativeHow to conduct the clinical trials successfully for 1/4 approved products by FDA-
dc.typeConference_Paper-
dc.identifier.emailYau, HKC: kcyau@hku.hk-
dc.identifier.emailWong, CKW: creanywo@hku.hk-
dc.identifier.hkuros307520-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats